Workflow
Cardiff Oncology(CRDF)
icon
Search documents
Cardiff Oncology(CRDF) - 2019 Q2 - Quarterly Report
2019-08-08 20:01
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBER 001-35558 TROVAGENE, INC. (Exact Name of registrant as specified in its charter) 11055 Flintkote Avenue, San Diego, California 921 ...
Cardiff Oncology(CRDF) - 2019 Q1 - Quarterly Report
2019-05-07 20:07
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBER 001-35558 TROVAGENE, INC. (Exact Name of registrant as specified in its charter) Delaware 27-2004382 (State or other jurisdiction ...
TrovaGene (TROV) Investor Presentation - Slideshow
2019-04-02 19:47
| --- | --- | |-------|-------| | | | | | | Forward-Looking Statements Certain statements in this presentation are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of words such as "anticipate," "believe," "forecast," "estimated" and "intend" or other similar terms or expressions that concern Trovagene's expectations, strategy, plans or intentions. These forward-looking statements are based on Trovagene's current expect ...
Cardiff Oncology(CRDF) - 2018 Q4 - Annual Report
2019-03-06 21:05
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 001-35558 TROVAGENE, INC. (Exact name of registrant as specified in its charter) Delaware 27-2004382 (State or other jurisdiction of incorp ...